Table S6. Disease severity of patients.
| Variables (%) | Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Total | P |
|---|---|---|---|---|---|---|
| Respiratory failure | 0 (0.0) | 2 (3.1) | 2 (3.8) | 15 (44.1) | 19 (9.4) | <0.001 |
| ICU | 4 (7.7) | 5 (7.7) | 4 (7.7) | 15 (44.1) | 28 (13.8) | <0.001 |
| Health care utilization in the past year | ||||||
| Hospitalization | 2 (3.8) | 1 (1.5) | 8 (15.4) | 7 (20.6) | 18 (8.9) | <0.001 |
| Emergency | 11 (21.2) | 5 (7.7) | 9 (17.3) | 12 (35.3) | 37 (18.2) | |
| Outpatient | 31 (59.6) | 27 (41.5) | 16 (30.8) | 13 (38.2) | 87 (42.9) | |
| None | 8 (15.4) | 32 (49.2) | 19 (36.5) | 2 (5.9) | 61 (30.0) | |
| ICS | ||||||
| High-dose | 0 (0.0) | 7 (10.7) | 3 (5.8) | 31 (91.2) | 41 (20.2) | <0.001 |
| Moderate-dose | 38 (73.1) | 24 (36.9) | 24 (46.2) | 2 (5.9) | 88 (43.3) | |
| Low-dose | 7 (13.5) | 24 (36.9) | 20 (38.5) | 1 (2.9) | 52 (25.6) | |
| No use | 7 (13.5) | 10 (15.4) | 5 (9.6) | 0 (0.0) | 22 (10.8) | |
| Medication use | ||||||
| No ICS | 7 (13.5) | 10 (15.4) | 5 (9.6) | 0 (0.0) | 22 (10.8) | <0.001 |
| ICS + LABA | 44 (84.6) | 49 (75.4) | 42 (80.8) | 18 (52.9) | 153 (75.4) | |
| ICS + LABA + LAMA | 1 (1.9) | 6 (9.2) | 3 (5.8) | 5 (14.7) | 15 (7.4) | |
| Oral or systemic CS | 0 (0.0) | 0 (0.0) | 2 (3.8) | 11 (32.4) | 13 (6.4) |
Data are presented as count (%). P value from chi-squared test of categorical variables between the four clusters. ICU, intensive care unit; ICS, inhaled corticosteroids; LABA, long-acting β-agonists; CS, corticosteroids; LAMA, long-acting muscarinic antagonist.